Diabetes and hypertension are common co-morbid associates and coexist in many of the cases. The study attempts to understand the two-way transition between diabetes and hypertension and the risk factors affecting the transition using the multistate model. The study used data from the first and second waves of IHDS. There is a significant rise in the level of diabetes and hypertension from 2004-05 to 2011-12. Except for transition from hypertension to diabetes, the probability of transition in all other transition decreases and the mean waiting time to stay in the healthy state increases after adjusting for several covariates. Increases in the level of smoking, drinking of alcohol, consumption of tobacco, body mass index, education and household income quintile are the major transition specific risk factors affecting the transition between diabetes and hypertension. And the risk of transitioning from a healthy state to hypertension is higher among females compared to males.
References
[1]
Qureshi, A.I., Suri, M.F.K., Kirmani, J.F., Divani, A.A. and Mohammad, Y. (2005) Is Prehypertension a Risk Factor for Cardiovascular Diseases? Stroke, 36, 1859-1863.
https://doi.org/10.1161/01.STR.0000177495.45580.f1
[2]
Wu, S., Huang, Z., Yang, X., Li, S., Zhao, H., Ruan, C., Wu, Y., Xin, A., Li, K., Jin, C. and Cai, J. (2013) Cardiovascular Events in a Prehypertensive Chinese Population: Four-Year Follow-Up Study. International Journal of Cardiology, 167, 2196-2199.
https://doi.org/10.1016/j.ijcard.2012.05.123
[3]
Raina, S.K., Chander, V., Raina, S., Kumar, D., Grover, A. and Bhardwaj, A. (2015) Hypertension and Diabetes as Risk Factors for Dementia: A Secondary Post-Hoc Analysis from North-West India. Annals of Indian Academy of Neurology, 18, 63.
[4]
Nirmalan, P.K., Robin, A.L., Katz, J., Tielsch, J.M., Thulasiraj, R.D., Krishnadas, R. and Ramakrishnan, R. (2004) Risk Factors for Age Related Cataract in a Rural Population of Southern India: The Aravind Comprehensive Eye Study. British Journal of Ophthalmology, 88, 989-994. https://doi.org/10.1136/bjo.2003.038380
[5]
Saxena, S., Mitchell, P. and Rochtchina, E. (2004) Five-Year Incidence of Cataract in Older Persons with Diabetes and Pre-Diabetes. Ophthalmic Epidemiology, 11, 271-277. https://doi.org/10.1080/09286580490510733
[6]
Mukesh, B.N., Le, A., Dimitrov, P.N., Ahmed, S., Taylor, H.R. and McCarty, C.A. (2006) Development of Cataract and Associated Risk Factors: The Visual Impairment Project. Archives of Ophthalmology, 124, 79-85.
https://doi.org/10.1001/archopht.124.1.79
[7]
Raman, R., Rani, P.K., Rachepalle, S.R., Gnanamoorthy, P., Uthra, S., Kumaramanickavel, G. and Sharma, T. (2009) Prevalence of Diabetic Retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study Report 2. Ophthalmology, 116, 311-318.
https://doi.org/10.1016/j.ophtha.2008.09.010
[8]
Kumar, A., Goel, M.K., Jain, R.B., Khanna, P. and Chaudhary, V. (2013) India towards Diabetes Control: Key Issues. The Australasian Medical Journal, 6, 524.
https://doi.org/10.4066/AMJ.2013.1791
[9]
Joshi, S.R. and Parikh, R.M. (2007) India; the Diabetes Capital of the World: Now Heading towards Hypertension. Journal: Association of Physicians of India, 55, 323.
[10]
Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K. and He, J. (2005) Global Burden of Hypertension: Analysis of Worldwide Data. The Lancet, 365, 217-223. https://doi.org/10.1016/S0140-6736(05)17741-1
[11]
Lawes, C.M., Vander Hoorn, S., Law, M.R., Elliott, P., MacMahon, S. and Rodgers, A. (2006) Blood Pressure and the Global Burden of Disease 2000. Part 1: Estimates of Blood Pressure Levels. Journal of Hypertension, 24, 413-422.
https://doi.org/10.1097/01.hjh.0000199801.72563.6f
[12]
Arauz-Pacheco, C., Parrott, M.A. and Raskin, P. (2002) The Treatment of Hypertension in Adult Patients with Diabetes. Diabetes Care, 25, 134-147.
https://doi.org/10.2337/diacare.25.1.134
[13]
Mohan, V., Deepa, M., Deepa, R., Shanthirani, C.S., Farooq, S., Ganesan, A. and Datta, M. (2006) Secular Trends in the Prevalence of Diabetes and Impaired Glucose Tolerance in Urban South India—The Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia, 49, 1175-1178.
https://doi.org/10.1007/s00125-006-0219-2
[14]
Anjana, R.M., Pradeepa, R., Deepa, M., Datta, M., Sudha, V., Unnikrishnan, R., Bhansali, A., Joshi, S.R., Joshi, P.P., Yajnik, C.S. and Dhandhania, V.K. (2011) Prevalence of Diabetes and Prediabetes (Impaired Fasting Glucose and/or Impaired Glucose Tolerance) in Urban and Rural India: Phase I Results of the Indian Council of Medical Research India Diabetes (ICMR-INDIAB) Study. Diabetologia, 54, 3022-3027. https://doi.org/10.1007/s00125-011-2291-5
[15]
Gupta, R. (2004) Trends in Hypertension Epidemiology in India. Journal of Human Hypertension, 78, 73-78. https://doi.org/10.1038/sj.jhh.1001633
[16]
Gupta, R. (2016) Convergence in Urban-Rural Prevalence of Hypertension in India. Journal of Human Hypertension, 30, 79. https://doi.org/10.1038/jhh.2015.48
[17]
Colditz, G.A., Willett, W.C., Rotnitzky, A. and Manson, J.E. (1995) Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women. Annals of Internal Medicine, 122, 481-486. https://doi.org/10.7326/0003-4819-122-7-199504010-00001
[18]
Hu, F.B., Manson, J.E., Stampfer, M.J., Colditz, G., Liu, S., Solomon, C.G. and Willett, W.C. (2001) Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women. New England Journal of Medicine, 345, 790-797.
https://doi.org/10.1056/NEJMoa010492
[19]
Kannel, W.B. and McGee, D.L. (1979) Diabetes and Cardiovascular Disease: The Framingham Study. JAMA, 241, 2035-2038.
https://doi.org/10.1001/jama.1979.03290450033020
[20]
American Diabetes Association (1998) Economic Consequences of Diabetes Mellitus in the US in 1997. Diabetes Care, 21, 296-309.
https://doi.org/10.2337/diacare.21.2.296
[21]
Arredondo, A. and Zúniga, A. (2004) Economic Consequences of Epidemiological Changes in Diabetes in Middle-Income Countries: The Mexican Case. Diabetes Care, 27, 104-109. https://doi.org/10.2337/diacare.27.1.104
[22]
Muszbek, N., Brixner, D., Benedict, A., Keskinaslan, A. and Khan, Z.M. (2008) The Economic Consequences of Noncompliance in Cardiovascular Disease and Related Conditions: A Literature Review. International Journal of Clinical Practice, 62, 338-351. https://doi.org/10.1111/j.1742-1241.2007.01683.x
[23]
Longini Jr., I.M., Clark, W.S., Byers, R.H., Ward, J.W., Darrow, W.W., Lemp, G.F. and Hethcote, H.W. (1989) Statistical Analysis of the Stages of HIV Infection Using a Markov Model. Statistics in Medicine, 8, 831-843.
https://doi.org/10.1002/sim.4780080708
[24]
Gentleman, R.C., Lawless, J.F., Lindsey, J.C. and Yan, P. (1994) Multi-State Markov Models for Analysing Incomplete Disease History Data with Illustrations for HIV Disease. Statistics in Medicine, 13, 805-821. https://doi.org/10.1002/sim.4780130803
[25]
Marshall, G. and Jones, R.H. (1995) Multi-State Models and Diabetic Retinopathy. Statistics in Medicine, 14, 1975-1983. https://doi.org/10.1002/sim.4780141804
[26]
Satten, G.A. and Longini Jr., I.M. (1996) Markov Chains with Measurement Error: Estimating the “True” Course of a Marker of the Progression of Human Immunodeficiency Virus Disease. Journal of the Royal Statistical Society: Series C (Applied Statistics), 45, 275-295. https://doi.org/10.2307/2986089
[27]
Andersen, P.K. (1988) Multistate Models in Survival Analysis: A Study of Nephropathy and Mortality in Diabetes. Statistics in Medicine, 7, 661-670.
https://doi.org/10.1002/sim.4780070605
[28]
Guihenneuc-Jouyaux, C., Richardson, S. and Longini Jr., I.M. (2000) Modeling Markers of Disease Progression by a Hidden Markov Process: Application to Characterizing CD4 Cell Decline. Biometrics, 56, 733-741.
https://doi.org/10.1111/j.0006-341X.2000.00733.x
[29]
Cox, D.R. and Miller, H.D. (1965) The Theory of Stochastic Process. Chapman and Hall, London.
[30]
Jackson, C. (2007) Multi-State Modeling with R: The MSM Package. MRC Biostatistics Unit, Cambridge.
[31]
Joshi, S.R., Saboo, B., Vadivale, M., Dani, S.I., Mithal, A., Kaul, U., Badgandi, M., Iyengar, S.S., Viswanathan, V., Sivakadaksham, N. and Chattopadhyaya, P.S. (2012) Prevalence of Diagnosed and Undiagnosed Diabetes and Hypertension in India—Results from the Screening India’s Twin Epidemic (SITE) Study. Diabetes Technology and Therapeutics, 14, 8-15. https://doi.org/10.1089/dia.2011.0243
[32]
Cheung, B.M. and Li, C. (2012) Diabetes and Hypertension: Is There a Common Metabolic Pathway? Current Atherosclerosis Reports, 14, 160-166.
https://doi.org/10.1007/s11883-012-0227-2
[33]
Gupta, R. and Guptha, S. (2010) Strategies for Initial Management of Hypertension. The Indian Journal of Medical Research, 132, 531.
[34]
International Diabetes Federation (2015) International Diabetes Federation Diabetes Atlas. 7th Edition.
https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html
[35]
Gress, T.W., Nieto, F.J., Shahar, E., Wofford, M.R. and Brancati, F.L. (2000) Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. New England Journal of Medicine, 342, 905-912.
https://doi.org/10.1056/NEJM200003303421301
[36]
Paul, B., Sapra, B., Maheshwari, S. and Goyal, R.K. (2000) Role of Losartan Therapy in the Management of Diabetic Hypertension. The Journal of the Association of Physicians of India, 48, 514-518.
[37]
Lago, R.M., Singh, P.P. and Nesto, R.W. (2007) Diabetes and Hypertension. Nature Clinical Practice Endocrinology and Metabolism, 3, 667-668.
https://doi.org/10.1038/ncpendmet0638
[38]
Mahler, R.J. (1990) Diabetes and Hypertension. Hormone and Metabolic Research, 22, 599-607. https://doi.org/10.1055/s-2007-1004983
[39]
WHO (1996) Hypertension Control: Report of a WHO Expert Committee.
[40]
Mogensen, C.E. (1998) Combined High Blood Pressure and Glucose in Type 2 Diabetes: Double Jeopardy. British Medical Journal, 317, 693-695.
https://doi.org/10.1136/bmj.317.7160.693
[41]
Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A. and Nathan, D.M. (2002) Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The New England Journal of Medicine, 346, 393-403. https://doi.org/10.1056/NEJMoa012512
[42]
WHO (2000) Global Strategy for the Prevention and Control of Non-Communicable Diseases.
[43]
WHO (2009) Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks.
[44]
Singer, J.D., Willett, J.B. and Willett, J.B. (2003) Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford University Press, Oxford.
